| For: | Meng LL, Di YP, Ma L, Qu BL. Advances in prostate cancer treatment with moderate and ultra-hypofractionated radiotherapy. World J Clin Oncol 2025; 16(12): 112735 [PMID: 41480171 DOI: 10.5306/wjco.v16.i12.112735] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v16/i12/112735.htm |
| Number | Citing Articles |
| 1 |
Atsuto Katano, Hideomi Yamashita. Linear Accelerator–Based Stereotactic Body Radiotherapy of 36.25 Gy in Five Fractions for Localised Prostate Cancer: A Retrospective Single‐Institution Cohort Study. Journal of Medical Imaging and Radiation Oncology 2026; doi: 10.1111/1754-9485.70202
|
| 2 |
Nada Samir Shams El-Din El-Behiri, Mohamed A Alm El-Din, Asmaa Mohamed Alkady, Rabab Mahmoud Moussa, Mohamed Mohamed Elshebeny. Hypofractionated versus conventional IMRT in unfavorable intermediate- and high-risk prostate cancer: A phase II comparative study of PSA kinetics, dosimetric and toxicity outcomes. The French Journal of Urology 2026; 36(5) doi: 10.1016/j.fjurol.2026.103104
|